Pegcetacoplan

FDA Drug Profile — Syfovre, Empaveli

Drug Details

Generic Name
Pegcetacoplan
Brand Names
Syfovre, Empaveli
Application Number
NDA217171
Sponsor
Bachem AG
NDC Codes
3
Dosage Forms
POWDER, INJECTION, SOLUTION
Routes
INTRAVITREAL, SUBCUTANEOUS
Active Ingredients
PEGCETACOPLAN

Indications and Usage

1 INDICATIONS AND USAGE SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). SYFOVRE is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). ( 1 )